Europe Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)

Name: Europe Embolization Agents Market
SKU: Medical Device
Rating: 4.8 (16 reviews)

Market Introduction

The Europe embolization agents market includes the consolidated markets for Germany, France, UK, Spain, Italy, and rest of Europe. Europe occupies a significant position in the global embolization agents market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is expected due to aging population, increasing prevalence of cancers and brain aneurysms, and rising numbers of product launches are likely to be the major factors driving the growth of this market in the Europe. Brain aneurysms may further lead to bleeding in the brain which is known as hemorrhagic stroke. The prevalence of stroke in Germany has been recorded during the recent years. As per the data published in The Burden of Stroke in Europe report conducted by King’s College London for the Stroke Alliance for Europe, the incidence of stroke is around 88,922 cases of stroke, which is 51.7 strokes per 100,000 inhabitants annually in Germany. The prevalence of stroke in Germany was around 526,774, accounting for 338.5 strokes per 100,000 inhabitants. The country also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. Estimates reveal, the incidence of strokes in Germany is expected to increase by 30% by the end of 2035. Also, the prevalence and mortality rates are expected to rise to 19% and 40%, respectively by 2035. Some of the prevalent risk factors leading to stroke are, high blood pressure, smoking, high cholesterol, and raised glucose level. Market players in the country are also focusing on launch of innovative products. Such developments are also projected to accelerate market growth. For instance, in April 2020, Phenox GmbH, a pioneer of innovative technologies for neurovascular diseases, launched the new p64 MW Flow Modulation Device. The p64 MW Flow Modulation device, a next-generation stent-like device and is intended to divert blood flow away from the aneurysm

In Europe, Italy, Spain, and France have reported the highest number of COVID-19 cases. According to the European Centre for Disease Prevention and Control (ECDC), as of June 2021, Europe has registered 736,553 deaths so far due to COVID-19. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day than the daily case count reported during the first wave of the pandemic. As per the ECDC, lockdowns are being reintroduced in the UK, Spain, Italy, and Ireland. Moreover, many country governments are working towards boosting up their cell therapy, gene therapy, and regenerative medicine capabilities. Additionally, in the UK, the practice of cancer and neurological diseases has changed. Increasing COVID-19 has affected the diagnosis and treatment of diseases, due to the diversification of the medical workforce and decision to focus on treating the critically ill. Many research organizations are focusing more on COVID studies and are working hard to better understand the virus. The European Academy of Neurology (EAN) has launched a survey on neurological symptoms in COVID-19 patients to better understand the neurological manifestations of the disease. Thus, the growing focus on SARS-CoV-2 has limited the Europe embolization agents market growth in the last two years.

Get more information on this report :

Market Overview and Dynamics

The embolization agents market in Europe is expected to grow from US$ 795.79 million in 2021 to US$ 1,282.95 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. In September 2021 Medtronic embolization device hit with another Class I recall detached coils. FDA has classified another recall of Medtronic's Pipeline Flex embolization device for treating brain aneurysms as a Class I event after receiving reports of 59 malfunctions, 10 serious injuries and two deaths. In July 2021 Terumo Introduces New AZUR Vascular Plug and PG Pro Peripheral Microcatheter Embolization System the first and only plug compatible with a microcatheter and capable of occluding arteries up to 8mm in diameter. The newest addition to Terumo's extensive embolization portfolio is recommended for use in arteries of the peripheral vasculature to limit or stop blood flow. Further, in May 2021, Shanghai MicroPort NeuroTech Co., Ltd. received CE approval from the European Union for its Numen Coil Embolization System (Numen) and Numen FR Coil Detachment System (Numen FR). These are used for coil embolization procedures for the treatment of intracranial aneurysm. The company focuses on research and development activities to develop innovative solutions on cerebrovascular and neuro interventions. Additionally, in December 2020, Terumo Corporation launched WEB Embolization System (Product name in Japan: Woven EndoBridge Device), an intrasaccular aneurysm treatment device, in Japan. The WEB device is an innovative intrasaccular flow disruptor device and provides new treatment options for brain aneurysm cases. Such advancements based on modern technologies are likely to introduce new future trends in the Europe embolization agents market the coming years.

Key Market Segments

Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, others. The beads/particles segment held the largest share of the market in 2020. Based on coils the market is divided into detachable coils and pushable coils. The pushable coils segment held the largest share of the market in 2020. Based on beads/particles the market is divided into spherical and non-spherical. The pushable non-spherical segment held the largest share of the market in 2020. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2020, the oncology segment is likely to hold the largest share of the market. The embolization agents market by end user, is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held the largest share of the market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the embolization agents market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Boston Scientific Corporation; Cook Medical LLC; DePuy Synthes; KANEKA CORPORATION; Medtronic; Merit Medical Systems Inc; Penumbra, Inc.; Stryker Corporation; and Terumo Corporation among others.

Reasons to buy report

To understand the Europe embolization agents market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe embolization agents market
Efficiently plan M&A and partnership deals in Europe embolization agents market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe embolization agents market
Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE EMBOLIZATION AGENTS MARKET SEGMENTATION

By Product

Coils
- Detachable Coils
- Pushable Coils
Beads/ Particles
- Spherical
- Non-Spherical
Plugs
Detachable Balloons
Glue
Sponge
Liquid Embolics
Sclerosants
Precipitating Agents
Others

By Application

By End User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

By Country

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Embolization Agents Market – By Product

1.3.2 Europe Embolization Agents Market – By Application

1.3.3 Europe Embolization Agents Market – By End User

1.3.4 Europe Embolization Agents Market – By Country

2. Europe Embolization Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Embolization Agents Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Europe Embolization Agents Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing in the Incidence of Tumors and Aneurysms

5.1.1 Rise Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Huge Cost of Embolization Agents

5.3 Market Opportunities

5.3.1 Rising Geriatric Population Base

5.4 Future Trends

5.4.1 Technological Advancements in Embolization Products and Procedures

5.5 Impact analysis

6. Embolization Agents Market – Europe Analysis

6.1 Europe Embolization Agents Market Revenue Forecast and Analysis

7. Europe Embolization Agents Market Analysis – By Product

7.1 Overview

7.2 Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3 Coils

7.3.1 Overview

7.3.2 Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Detachable Coils

7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2 Pushable Coils

7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Beads/Particles

7.4.1 Overview

7.4.2 Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Spherical

7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2 Non-Spherical

7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Plugs

7.5.1 Overview

7.5.2 Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Detachable Balloons

7.6.1 Overview

7.6.2 Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7 Glue

7.7.1 Overview

7.7.2 Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8 Sponge

7.8.1 Overview

7.8.2 Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9 Liquid Embolics

7.9.1 Overview

7.9.2 Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10 Sclerosants

7.10.1 Overview

7.10.2 Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11 Precipitating Agents

7.11.1 Overview

7.11.2 Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12 Others

7.12.1 Overview

7.12.2 Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8. Europe Embolization Agents Market Analysis – By Application

8.1 Overview

8.2 Europe Embolization Agents Market, by Application 2021 & 2028 (%)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Urology

8.5.1 Overview

8.5.2 Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Cardiology

8.6.1 Overview

8.6.2 Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Peripheral Vascular Diseases

8.7.1 Overview

8.7.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Embolization Agents Market Analysis – By End User

9.1 Overview

9.2 Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Cardiac Centers

9.4.1 Overview

9.4.2 Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Embolization Agents Market – Country Analysis

10.1 Europe: Embolization Agents Market

10.1.1 Overview

10.1.2 Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Germany: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2.1 Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.2 Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4 Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2.1 France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.2 France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4 France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2.1 UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.2 UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.4 UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2.1 Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3 Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5 Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1 Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2 Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.2.1 Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2.2 Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.3 Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.4 Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1 Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2 Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.2.1 Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2.2 Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.3 Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.4 Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Europe Embolization Agents Market

11.1 Europe: Impact Assessment Of COVID-19 Pandemic

12. Europe Embolization Agents Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Medtronic

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Terumo Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boston Scientific Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Stryker Corporation

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Penumbra, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Merit Medical Systems Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DePuy Synthes

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 KANEKA CORPORATION

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2. Germany: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)

Table 4. Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 5. Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 9. France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10. France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11. France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13. UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 14. UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15. UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 24. Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 25. Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27. Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28. Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 31. Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32. Organic Developments Done by Companies

Table 33. Inorganic Developments Done by Companies

Table 34. Glossary of Terms, Europe Embolization Agents Market

LIST OF FIGURES

Figure 1. Europe Embolization Agents Market Segmentation

Figure 2. Europe Embolization Agents Market Segmentation, By Country

Figure 3. Europe Embolization Agents Market Overview

Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in Europe Embolization Agents Market

Figure 5. UK to Show Significant Growth During Forecast Period

Figure 6. Europe and PEST Analysis

Figure 7. Europe Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8. Europe Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10. Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11. Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21. Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28. Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33. Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34. Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39. Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000